Despite decades of research proving exercise saves lives, the world still lacks a coordinated global strategy to get people moving. Here's why this gap exists—and what we can do to close it.
On dusty roads through Western Kenya's villages, a group of courageous women are defying traditional expectations and saving lives—one motorcycle ride at a time. Meet the female bike riders who've become lifelines for pregnant women in remote rural communities.
After years of limited progress, tuberculosis research is experiencing a major breakthrough with new vaccines and MDR-TB treatments entering Phase III clinical trials. With TB cases projected to reach 4.5 million across major markets by 2033, these developments could be transformative for global health.
What if one of the most cost-effective solutions to world hunger was already hiding in your pantry? Food fortification—a simple yet powerful strategy of adding essential nutrients to everyday staples—is quietly preventing billions of nutrient deficiencies each year. But according to new research, we're only scratching the surface of its potential.
Tuberculosis remains one of Africa's most pressing public health challenges, draining resources and devastating communities across the continent. The Africa CDC is sounding the alarm, calling for coordinated action from governments, health systems, and international partners to finally turn the tide against this preventable disease.
A groundbreaking new analysis reveals a troubling gap in medical research: African populations are dramatically underrepresented in the clinical trials that determine how heart disease is treated worldwide. This absence has serious implications for healthcare equity and patient outcomes across the continent.
Scientists have discovered a crucial genetic mechanism that allows Mycobacterium tuberculosis to adapt and survive in different hosts. This breakthrough in understanding how the bacterium reshapes its genetic networks could revolutionize our approach to fighting one of humanity's deadliest diseases.
A troubling new study reveals that resistance to colistin—one of medicine's final weapons against dangerous bacteria—is spreading rapidly across Africa. This emerging threat could have devastating consequences for public health in a region already struggling with limited treatment options.